Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:IMR) ) has shared an announcement.
Imricor Medical Systems, Inc. announced a change in the director’s interest, with Ms. Anita Messal acquiring 38,700 Class A common stock shares under the company’s Equity Incentive Plan. This change, approved at the recent AGM, reflects ongoing strategic efforts to align leadership incentives with company performance, potentially impacting stakeholder confidence and the company’s market positioning.
The most recent analyst rating on (AU:IMR) stock is a Buy with a A$2.28 price target. To see the full list of analyst forecasts on Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:IMR Stock Forecast page.
More about Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
Imricor Medical Systems, Inc. operates in the medical technology industry, focusing on developing and commercializing innovative products for cardiac ablation procedures. The company is known for its MRI-compatible products, which aim to improve the safety and effectiveness of cardiac interventions.
Average Trading Volume: 417,906
See more insights into IMR stock on TipRanks’ Stock Analysis page.